PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones
NCT: NCT07272720 · RECRUITING
Brief Summary
Extracorporeal shockwave lithotripsy (ESWL) is a non-invasive standard treatment for kidney stones. This study will be conducted to evaluate the effectiveness of ESWL using MODULITH® SLX-F2 with stone tracking, compared to MODULITH® SLX-F2 without stone tracking, in adult patients with kidney stones, as measured by stone-free status.
Frequently Asked Questions
What is PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones?
PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones is a clinical trial registered under NCT07272720. Current status: RECRUITING.
What is the status of NCT07272720?
The current status of NCT07272720 (PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones) is: RECRUITING.
When did PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones start?
PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones started on 2025-12-11.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.